Elevated salivary cortisol predicts response to adjunctive immune modulation in treatment-resistant bipolar depression

Background: Adjunctive inflammatory treatments improve response and remission rates in treatment-resistant bipolar depression (TRBDD), but underlying mechanisms remain unclear. Given the association between hypothalamic-pituitary-adrenal (HPA) axis dysregulation and treatment-resistant depression, w...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Stephen Murata, Michael Murphy, Rajan Khanna, Debra Hoppensteadt, Jawed Fareed, Angelos Halaris
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2021-04-01
coleção:	Journal of Affective Disorders Reports
Assuntos:	Bipolar disorder Treatment-resistant bipolar depression Hypothalamic-pituitary-adrenal (HPA) axis Salivary cortisol Escitalopram Celecoxib
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2666915321000445
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!